Genomic Prediction

Genomic Prediction is a company in New Brunswick, United States. Its website presents LifeView Embryo Screening and Tests, which it describes as reducing the risk of miscarriage and genetic disease and increasing the success of fertility treatments. The site states that LifeView PGT is proven to provide improved accuracy, more available embryos for transfer, lower miscarriage rates and higher pregnancy rates, and that LifeView patients also have access to Embryo Health Scores. PGT options listed include PGT-A, PGT-A+ and PGT-M.

Genomic Prediction is a company in New Brunswick, United States. Its website presents LifeView Embryo Screening and Tests, described as reducing the risk of miscarriage and genetic disease and increasing the success of fertility treatments. The site states that LifeView PGT is proven to provide improved accuracy, more available embryos for transfer, lower miscarriage rates and higher pregnancy rates, and that LifeView patients also have access to Embryo Health Scores, which it says have been proven to reduce the risk of common diseases such as diabetes, cancer and heart disease in the embryo. PGT options listed include PGT-A, which screens embryos for aneuploidy so that an embryo with the correct number of chromosomes (euploid) can be selected for transfer; PGT-A+, done in conjunction with PGT-A, which indicates whether a chromosome abnormality originated from the egg (maternal) or sperm (paternal) and requires saliva samples from the patient, partner and/or gamete donor in addition to embryo samples; and PGT-M, designed for monogenic disorders, which are inherited conditions caused by genetic variants in a single gene.

LifeView™ PGT provides the most advanced genetic screening for the IVF embryo available.

• LifeView Embryo Screening and Tests

  Embryo screening and tests that the company says reduce the risk of miscarriage and genetic disease and increase the success of fertility treatments.

• PGT-A

  Screens embryos for aneuploidy so that an embryo with the correct number of chromosomes (euploid) can be selected for transfer.

• PGT-A+

  Done in conjunction with PGT-A; indicates whether a chromosome abnormality originated from the egg (maternal) or sperm (paternal), and requires saliva samples from the patient, partner and/or gamete donor in addition to embryo samples.

• PGT-M

  Designed for monogenic disorders, inherited conditions caused by genetic variants in a single gene.

• Embryo Health Score

  Available to LifeView patients; the company says it has been proven to reduce the risk of common diseases such as diabetes, cancer and heart disease in the embryo.

1. 1Preimplantation Genetic Testing | Genomic Predictionlifeview.com
2. 2Genomic Prediction (United States)wikidata.org